Clinical trial
Graphene Photothermal Adjuvant Therapy for Mild Corona Virus Disease 2019: A Prospective Randomized Controlled Trial
NCT05651815 is registered in ClinicalTrials.gov with Southeast University, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Graphene Photothermal Adjuvant Therapy for Mild Corona Virus Disease 2019: A Prospective Randomized Controlled Trial
- Lead sponsor
- Southeast University, China
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 22, 2022
- Completion date
- June 30, 2023
- Enrollment
- 270 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.